Navigation Links
Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents
Date:9/24/2008

Supports use of AHCC for immune enhancement during cold & flu season

PURCHASE, N.Y., Sept. 24 /PRNewswire/ -- A new paper published in Nutrition Reviews (Vol. 66(9):526-531) by Dr. Barry W. Ritz, PhD, Department of Bioscience and Biotechnology at Drexel University, has shown how AHCC impacts the immune response against a number of infectious agents.

The scientific review analyzed outcomes from in vivo studies evaluating the effect of AHCC supplementation on immune response following challenge with a variety of infectious agents such as the influenza (flu) virus, avian influenza (bird flu), Methicillin-Resistant Staphylococcus aureus (MRSA), Klebsiella pnuemoniae and Candida albicans. It was reported that supplementation with AHCC modulated immunity and delivered positive results in response to acute virus and bacterial infections.

"Studies with AHCC in multiple models of infectious disease, including the viruses that cause seasonal flu and bird flu, suggest that AHCC can stimulate the immune system and help the body respond to a broad spectrum of infectious threats," says Barry Ritz, Ph.D., Professor of Bioscience and Biotechnology at Drexel University.

Research completed with AHCC has shown that it activates important immune white blood cells including macrophages, NK cells and LAK cells. AHCC also induces the production of cytokines that serve as chemical messengers between cells. AHCC has been the subject of over 80 research studies worldwide including studies completed at Harvard University's Faulkner Hospital, Yale University and Columbia University Medical Center.

In addition to these studies, further investigation is being done examining the role of AHCC in humans for its ability to impact the T cells related to cellular immunity and determining if AHCC supplementation can serve as a beneficial vaccine adjuvant for the flu shot.

What is AHCC (Active Hexose Correlated Compound)?

AHCC is derived from the h
'/>"/>

SOURCE AHCC Research Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
3. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
4. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
5. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
6. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
7. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
8. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
9. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
10. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
11. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... AVIV, Israel , July 23, 2014 /PRNewswire/ ... ., a portfolio company of Trendlines Agtech ... one of Israel,s leading ... http://photos.prnewswire.com/prnh/20140121/666259-a) , Valentis,s technology combines nanocrystalline ... plant pulp waste, with additional nanoparticles to produce ...
(Date:7/23/2014)... 23, 2014 DuPont Pioneer announced today ... vice president of Agricultural Biotechnology (ABT), effective July 21, ... served most recently as president, chief executive officer and ... leadership in the seed and crop protection industry to ... E. Schickler , president of DuPont Pioneer. “I am ...
(Date:7/23/2014)... - BioAmber Inc. (NYSE: BIOA ), ... that the underwriters of its common stock offering ... additional 420,000 shares of common stock at the ... underwriting discounts and commissions, in connection with its ... of common stock, bringing the expected net proceeds ...
(Date:7/23/2014)... July 23, 2014 regulated information -- UCB today ... development pipeline with positive topline results from the ... study was designed to evaluate the efficacy and ... mg/day, without titration) compared to placebo, as adjunctive ... seizures, not fully controlled despite treatment with one ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7
... Applied scientists at the Harvard School of Engineering and ... Photonics in Hamamatsu City, Japan, have demonstrated, for the ... of the emitted radiation, known as polarization, can be ... door to a wide range of applications in photonics ...
... BAX ), will host a quarterly conference call ... April 16, 2009, at 8:30 a.m. Eastern Time (7:30 a.m. ... (domestic) or 703-639-1156 (international). Please dial into the call ... call for the operator to connect you.This call is being ...
... Structure By Completing the Elimination of All Previously Outstanding ... and MTA: CTIC) today announced that it has agreed ... Preferred Stock and warrants in a registered offering to ... for $15 million cash, shares of Series 1 Preferred ...
Cached Biology Technology:Scientists demonstrate laser with controlled polarization 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $15 Million of Preferred Stock 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $15 Million of Preferred Stock 3
(Date:7/23/2014)... crucial for providing essential fatty acids and energy ... There has been concern that soybean-based emulsions could ... to its composition. Combination lipid emulsions based on ... been developed to address this concern. , However, ... concern may be unwarranted, according to a review ...
(Date:7/22/2014)... consists of both still images and video of ... research. Forty-four still images were chosen from more ... staff, and alumni representing more than 25 different ... than 50 submissions. , Zach Donnell, a graduate ... 2014 organizers, noted that the exhibit highlights the ...
(Date:7/22/2014)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2014. Revenue ... increase of 53% compared to $4.4 million in the same ... the second quarter of 2014 was $1.4 million compared to ... in revenue and operating income was driven by higher sales ...
Breaking Biology News(10 mins):Art of Science 2014 2Aware, Inc. Reports Second Quarter 2014 Financial Results 2Aware, Inc. Reports Second Quarter 2014 Financial Results 3Aware, Inc. Reports Second Quarter 2014 Financial Results 4Aware, Inc. Reports Second Quarter 2014 Financial Results 5Aware, Inc. Reports Second Quarter 2014 Financial Results 6Aware, Inc. Reports Second Quarter 2014 Financial Results 7
... Arthur Conan Doyle,s account of an isolated community of dinosaurs ... has no less appeal now than it did when it ... to recreate the lost world of dinosaurs, but today the ... evidence suggests that dinosaur bones from the Ojo Alamo Sandstone ...
... Bourne, a computational biologist and professor with the University ... 2009 Benjamin Franklin Award this week in recognition of ... and open dissemination of science and scientific data. , ... at the annual meeting of the Bioinformatics Organization in ...
... Key Largo, Fla. April 27, 2009 A new ... technique for reattaching large sponges that have been dislodged from ... restoration of other large sponge species removed by human activities ... barrel sponge were removed and reattached at Conch Reef off ...
Cached Biology News:Evidence of the 'Lost World' -- did dinosaurs survive the end Cretaceous extinctions? 2Open access advocate Philip E. Bourne to receive 2009 Benjamin Franklin Award 2Open access advocate Philip E. Bourne to receive 2009 Benjamin Franklin Award 3Large sponges may be reattached to coral reefs 2
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
Annexin V Binding Buffer, 10X Concentrate Buffer , 50 ml Consult technical datasheet for details....
Biology Products: